Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

6.28
Delayed Data
As of Aug 28
 +0.30 / +5.02%
Today’s Change
3.33
Today|||52-Week Range
6.85
+50.60%
Year-to-Date

Today’s Trading

Previous close5.98
Today’s open5.97
Day’s range5.97 - 6.30
Volume201,205
Average volume (3 months)474,471
Market cap$380.0M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-100.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+31.00%
P/E ratioNM
Price/Sales2.68
Price/Book6.26

Competitors

 Today’s
change
Today’s
% change
NVTAInvitae Corp+1.44+15.25%
GNMKGenMark Diagnostics ...+0.59+6.26%
CTICCTi Biopharma Corp+0.03+1.91%
RDNTRadNet Inc-0.17-2.74%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateOctober 21, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$87.1M
Annual profit (last year)$1.1M
Net profit margin1.30%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. VanOort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers